203 related articles for article (PubMed ID: 12626293)
21. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
22. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
[TBL] [Abstract][Full Text] [Related]
23. Common clinicopathological features of the patients with chronic hepatitis B virus infection who developed hepatocellular carcinoma after seroconversion to anti-HBs--a consideration of the pathogenesis of HBV-induced hepatocellular carcinoma and a strategy to inhibit it.
Tsuboi Y; Ohkoshi S; Yano M; Suzuki K; Tsubata SS; Ishihara K; Ichida T; Sugitani S; Shibazaki K; Aoyagi Y
Hepatogastroenterology; 2006; 53(67):110-4. PubMed ID: 16506387
[TBL] [Abstract][Full Text] [Related]
24. [Behavior of HBs Ag and HBs Ab in chronic hepatitis].
De Bellis G; Di Martino G; Russo N
Boll Ist Sieroter Milan; 1976; 55(2):164-7. PubMed ID: 1023884
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of the study of antibodies and complement in chronic hepatopathies].
Naccarato R; Farini R; Chiaramonte M
Minerva Med; 1978 Aug; 69(38):2573-9. PubMed ID: 309566
[No Abstract] [Full Text] [Related]
28. [Prevalence of HBSAG in blood donors and patients at the central hospital of Maputo, Mozambique, 1985].
Pérez O; Lastre M; Miyar R; Valdemar Meneses L
Rev Cubana Med Trop; 1989; 41(3):355-61. PubMed ID: 2561797
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis B and C viruses in hepatocellular carcinoma in Senegal].
Ka MM; Ndiaye MF; Herve P; Legueno B; Diop BM; Dangou JM; Niang A; Woto-Gaye G; Mendes V; Diop TM; Ndiaye PD; Bao O
Dakar Med; 1996; Spec No():59-62. PubMed ID: 14520992
[No Abstract] [Full Text] [Related]
30. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
32. Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
Mahmood S; Niiyama G; Kamei A; Izumi A; Nakata K; Ikeda H; Suehiro M; Kawanaka M; Togawa K; Yamada G
Liver Int; 2005 Apr; 25(2):220-5. PubMed ID: 15780042
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis G virus infection in patients with hepatocellular carcinoma in Recife, Brazil.
Leão-Filho GC; Lopes EP; Ferraz AA; Moura I; Pernambuco JR; Reis C; Silva AE; Ferraz ML
Jpn J Clin Oncol; 2007 Aug; 37(8):632-6. PubMed ID: 17704535
[TBL] [Abstract][Full Text] [Related]
34. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
35. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
36. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
37. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
Libman E; Stojsić S; Marton B; Lemberger J
Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
[No Abstract] [Full Text] [Related]
38. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis.
Sagnelli E; Pasquale G; Coppola N; Marrocco C; Scarano F; Imparato M; Sagnelli C; Scolastico C; Piccinino F
J Med Virol; 2005 Feb; 75(2):222-6. PubMed ID: 15602732
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
[No Abstract] [Full Text] [Related]
40. Study of the causes of higher mortality rates from chronic liver diseases in Tokushima Prefecture.
Kamamura M; Honda H; Inoue H; Shinomiya H; Kubo K; Tsutsui A; Muguruma N; Shibata H; Shimizu I; Ito S
J Med Invest; 2002 Aug; 49(3-4):163-71. PubMed ID: 12323006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
